Singapore: Clinical research firm, AMRI, has received a 10-year federal contract award from the National Institutes of H...
Singapore: Singapore start-up and Scotland based TauRx Therapeutics is progressing in its two Phase III clinical trials ...
Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209...
Singapore: Taiwan based Genovate Biotechnology and ScinoPharm have jointly developed the highly potent oral generic drug...
Singapore: Global biopharmaceutical company, Roche, has acquired InterMune, a biotechnology company focused on the resea...
Nasdaq-listed Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement for the develop...
Tokyo: Japan's Daiichi Sankyo Company Limited has announced details of the application for its Take a New Challenge for ...
Singapore: Australia biotech firm, Prescient Therapeutics, a clinical stage oncology company, has secured agreement from...
Singapore: European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing a...
Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has bee...
Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...
Singapore: Japan's Tokai Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel therapi...
Singapore: A study conducted on Biogen and Elan Pharmaceuticals's natalizumab has been shown to be effective for treatin...
Singapore: Roche and AstraZeneca entered into a collaboration to share early research data generated by Matched Molecula...
Singapore: European Medicines Agency's (EMA) Committee for Medicinal Product for Human Use (CHMP) has issued a negative ...
Singapore: HUYA Bioscience International has entered into a collaborative partnership with Shanghai Zhangjiang Biotech a...
Singapore: India-based Zydus Cadila and Pieris, a next generation therapeutic protein R&D company, have entered int...
Singapore: Kowa Pharmaceuticals America and Eli Lilly and Company revealed results of the PREVAIL study that was held in...
